| oxaliplatin / Generic mfg. |
NCT00761241: Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT |
|
|
| Completed | 2 | 40 | US | Gemcitabine, Docetaxel, 5FU, Oxaliplatin, Alpha-interferon, Abdominal/pelvic radiation therapy, Pancreaticoduodenectomy | Benaroya Research Institute, Sanofi | Pancreatic Cancer | 03/10 | 04/10 | | |
NCT00338039: Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients |
|
|
| Completed | 2 | 69 | US | Cetuximab, C225, Erbitux, IMC-C225, Gemcitabine, Gemzar, Gemcitabine Hydrochloride, Oxaliplatin, Eloxatin, Capecitabine, Xeloda, Radiotherapy, XRT | M.D. Anderson Cancer Center, Bristol-Myers Squibb | Pancreatic Cancer | 06/11 | 06/11 | | |
NCT01454180 / 2011-001017-13: Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets |
|
|
| Completed | 2 | 31 | Europe | gemcitabine, or gemcitabine and capecitabine, or gemcitabine and erlotinib, or FOLFIRINOX, or FOLFOX, or FOLFIRI., Gemcitabine, Gemcitabine-Capecitabine, Gemcitabine-Erlotinib, FOLFOXIRI, FOLFOX, FOLFIRI | Centro Nacional de Investigaciones Oncologicas CARLOS III, Hospital Universitario de Fuenlabrada, Apices Soluciones S.L., Grupo Hospital de Madrid | Advanced Pancreatic Carcinoma | 10/11 | 12/14 | | |
NCT00585078: Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma |
|
|
| Completed | 2 | 40 | US | Capecitabine, Xeloda, Oxaliplatin, Eloxatin | Beth Israel Deaconess Medical Center, Sanofi | Pancreatic Cancer | 12/11 | 12/11 | | |
NCT00456599: Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer |
|
|
| Completed | 2 | 71 | US, Canada | gemcitabine, Gemzar, oxaliplatin, Eloxatin, Radiation, RT | University of Michigan Rogel Cancer Center, Sanofi, Johns Hopkins University, Princess Margaret Hospital, Canada, Ohio State University | Pancreatic Cancer | 05/12 | 01/13 | | |
NCT00183820: Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma |
|
|
| Completed | 2 | 30 | US | paclitaxel, gemcitabine, and oxaliplatin | University of Southern California, Sanofi | Testicular Cancer, Germ Cell Neoplasm | 12/15 | 08/16 | | |
NCT02195180 / 2013-004262-34: Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma |
|
|
| Completed | 2 | 141 | Europe | ERY001, L asparaginase encapsulated in erythrocytes, Gemcitabine, 5-fluoro-uracil/oxaliplatin/leucovorin (folfox) | ERYtech Pharma | Pancreatic Adenocarcinoma Metastatic | 02/17 | 11/17 | | |
NCT00242190: Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer |
|
|
| Completed | 1/2 | 40 | US | oxaliplatin, gemcitabine, radiation therapy | University of Michigan Rogel Cancer Center, Sanofi-Synthelabo | Pancreatic Neoplasms | 03/06 | 02/10 | | |
CORGI, NCT01016639: Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer |
|
|
| Completed | 1/2 | 106 | Europe | oxaliplatin, capecitabine, radiotherapy | Lund University Hospital, Roche Pharma AG, Sanofi-Synthelabo | Stomach Cancer, Gall Bladder Cancer, Bile Ductus Cancer, Pancreas Cancer, Colorectal Cancer | 07/07 | 07/09 | | |
NCT00307723: Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer |
|
|
| Terminated | 1/2 | 52 | US | bevacizumab, 5-Fluorouracil, Oxaliplatin, gemcitabine, External Beam Radiation Therapy | Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Genentech, Inc., Sanofi | Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | 08/07 | 07/09 | | |
| Completed | 1/2 | 46 | Europe | gemcitabine, oxaliplatin, capecitabine | University Hospital, Basel, Switzerland, Swiss National Science Foundation, Swiss Cancer League, Roche Pharma AG, Sanofi | Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | 02/09 | 12/09 | | |
|
|
NCT00463840: Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer |
|
|
| Terminated | 1/2 | 24 | US | Oxaliplatin, Oxaliplatin: Eloxatin, 5FU, 5-Fluorouracil, Radiation, Surgery, FOLFOX 6 | NYU Langone Health, Sanofi | Pancreatic Cancer | 07/10 | 10/15 | | |
NCT01632306: A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer |
|
|
| Terminated | 1/2 | 13 | US | LY2090314, FOLFOX, FOLFOX (leucovorin + 5-fluorouracil + oxaliplatin), Gemcitabine, Gemzar, LY188011, Nab-paclitaxel | Eli Lilly and Company, Mayo Clinic | Pancreatic Cancer | 06/15 | 06/15 | | |
